Nvidia said its offerings will accelerate the training and inference of generative models used in Genentech’s “lab in the loop” framework, where extensive experimental data is fed into models for iterative drug discovery.
View Article on VentureBeat
AI,Business,AI, ML and Deep Learning,BioNeMo,Conversational AI,deep learning,DGX Cloud,drug discovery,Genentech,Generative AI,generative ai for drug discovery,molecular science,NLP,NVidia,Nvidia BioNeMo,Nvidia DGX Cloud,Roche
generative ai for drug discovery